Clinicopathological study of glomerular diseases associated with sarcoidosis: a multicenter study

The association between sarcoidosis and glomerular diseases has not been extensively investigated in a large series and the potential features of this uncommon association remain to be determined. METHODS: We retrospectively identified 26 patients with biopsy-proven glomerular lesions that occurred in a sarcoidosis context. Potential remission of glomerular disease and sarcoidosis under specific treatment (steroid and/or immunosuppressive agents) was recorded for all patients. Demographic, clinical and biological characteristics were assessed at the time of kidney biopsy for each patient. Therapeutic data were analyzed for all patients. RESULTS: Glomerular disease occurred after the diagnosis of sarcoidosis in 11 of 26 cases (42%) (mean delay of 9.7 years). In six patients (23%), the glomerulopathy preceded the sarcoidosis diagnosis (mean delay 8 years). In the last nine patients (35%), both conditions occurred simultaneously. The most frequent glomerular disease occurring in sarcoidosis patients was membranous nephropathy in eleven cases. Other glomerular lesions included IgA nephropathy in six cases, focal segmental glomerulosclerosis in four patients, minimal change nephrotic syndrome for three patients and proliferative lupus nephritis in two patients. Granulomatous interstitial nephritis was associated with glomerular disease in six patients and was exclusively found in patients in whom the both disease occurred simultaneously. In nine patients with simultaneous glomerular and sarcoidosis diseases, we observed a strong dissociation between glomerular disease and sarcoidosis in terms of steroid responsiveness. At the end of the follow-up (mean of 8.4 years), six patients had reached end-stage renal disease and three patients had died. CONCLUSIONS: A wide spectrum of glomerular lesions is associated with sarcoidosis. The close temporal relationship observed in some patients suggests common causative molecular mechanisms of glomerular injury but complete remission of both diseases in response to exclusive steroid therapy is infrequent.

Nephrotic syndrome, Glomerular disease, Kidney biopsy, Sarcoidosis

1. Baughman R.P., Lower E.E., du Bois R.M. Sarcoidosis. Lancet 2003; 361 (9363): 1111-1118

2. Iannuzzi M.C., Rybicki B.A., Teirstein A.S. Sarcoidosis. N Eng J Med 2007; 357 (21): 2153-2165

3. Baughman R.P., Teirstein A.S., Judson M.A. et al. Case Control Etiologic Study of Sarcoidosis research g: Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 2001; 164 (10 Pt 1): 1885-1889

4. Hunninghake G.W., Crystal R.G. Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity. N Eng J Med 1981; 305 (8): 429-434

5. Nunes H., Bouvry D., Soler P., Valeyre D. Sarcoidosis. Orpha-net J Rare Dis 2007; 2: 46

6. Berliner A.R., Haas M., Choi M.J. Sarcoidosis: the nephrologist’s perspective. Am J Kidney Dis 2006; 48 (5): 856-870

7. Gobel U., Kettritz R., Schneider W., Luft F. The protean face of renal sarcoidosis. JASN 2001; 12 (3): 616-623

8. Mahevas M., Lescure F.X., Boffa J.J. et al. Renal sarcoidosis: clinical, laboratory, and histologic presentation and outcome in 47 patients. Medicine (Baltimore) 2009; 88 (2): 98-106

9. Rajakariar R., Sharples E.J., Raftery M.J., et al. Sarcoid tubulointerstitial nephritis: long-term outcome and response to corticosteroid therapy. Kidney Int 2006; 70 (1): 165-169

10. Taylor R.G., Fisher C., Hoffbrand B.I. Sarcoidosis and membranous glomerulonephritis: a significant association. Br Med J (Clin Res Ed) 1982; 284 (6325): 1297-1298

11. Oliver Rotellar J.A., Garcia Ruiz C., Martinez Vea A. Response to prednisone in membranous nephropathy associated with sarcoidosis. Nephron 1990; 54 (2): 195

12. Toda T., Kimoto S., Nishio Y. et al. Sarcoidosis with membranous nephropathy and granulomatous interstitial nephritis. Intern Med 1999; 38 (11): 882-886

13. Kaaroud H., Fatma L.B., Beji S. et al. Interstitial and glomerular renal involvement in sarcoidosis. Saudi J Kidney Dis Transpl 2008; 19 (1): 67-71

14. Knehtl M., Debiec H., Kamgang P. et al. A case of phospholipase A(2) receptor-positive membranous nephropathy preceding sarcoid-associated granulomatous tubulointerstitial nephritis. Am J Kidney Dis 2011; 57 (1): 140-143

15. Parry R.G., Falk C. Minimal-change disease in association with sarcoidosis. Nephrol, Dial, Transplant 1997; 12 (10): 2159-2160 Mundlein E., Greten T., Ritz E. Graves’ disease and sarcoidosis in a patient with minimal-change glomerulonephritis. Nephrol, Dial, Transplant 1996; 11 (5): 860-862

16. Nishimoto A., Tomiyoshi Y., Sakemi T. et al. Simultaneous occurrence of minimal change glomerular disease, sarcoidosis and Hashimoto’s thyroiditis. Am J Nephrol 2000; 20 (5): 425-428

17. Lee S.M., Michael A.F. Focal glomerular sclerosis and sarcoidosis. Arch PatholLab Med 1978; 102 (11): 572-575

18. Veronese F.J., Henn Lde A., Faccin C.S. et al. Pulmonary sarcoidosis and focal segmental glomerulosclerosis: case report and renal transplant follow-up. Nephrol, Dial, Transplant 1998; 13 (2): 493-495

19. Peces R., de la Torre M., Sanchez-Fructuoso A., Escalada P. Focal segmental glomerulosclerosis associated with pulmonary sarcoidosis. Nephron 1993; 65 (4): 656-657

20. Murray F.E., Lombard M.G., Donohoe J.F. et al. Simultaneous presentation of IgA nephropathy and sarcoidosis. Sarcoidosis 1987; 4 (2): 134-136

21. Chung-Park M., Lam M., Yazdy A.M. IgA nephropathy associated with sarcoidosis. Am J Kidney Dis 1990; 15 (6): 601-602

22. Tateno S., Kobayashi Y., Kobayashi F.: A case of sarcoidosis revealed in the course of IgA nephropathy. Pathol Int 1994; 44 (5): 387-390

23. Taylor J.E., Ansell I.D. Steroid-sensitive nephrotic syndrome and renal impairment in a patient with sarcoidosis and IgA nephropathy. Nephrol, Dial, Transplant 1996; 11 (2): 355-356

24. Howard R.S., Gabriel R.: Glomerulonephritis in sarcoidosis: causal relationship unproven. Postgrad Med J 1992; 68 (797): 206-208

25. Hagiwara S., Ohi H., Eishi Y. et al. A case of renal sarcoidosis with complement activation via the lectin pathway. Am J Kidney Dis 2005; 45 (3): 580-587

26. Stehl et al. Statement on sarcoidosis: Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) Orphanet J Rare Dis 2013; 8 (65): 9 -10

27. Scadding J.G. Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years’ observation. Br Med J 1961; 2 (5261): 1165-1172

28. Levey A.S., Eckardt K.U., Tsukamoto Y. et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005; 67 (6): 2089-2100

29. Audard V., Larousserie F., Grimbert P. et al. Minimal change nephrotic syndrome and classical Hodgkin’s lymphoma: report of 21 cases and review of the literature. Kidney Int 2006; 69 (12): 2251-2260

30. D‘Agati V.D., Fogo A.B., Bruijn J.A., Jennette J.C. Pathologic classification of focal segmental glomerulosclerosis: a working proposal. Am J Kidney Dis 2004; 43 (2): 368-382

31. Glassock R.J. Human idiopathic membranous nephropathy-a mystery solved? N Eng J Med 2009; 361 (1): 81-83

32. Cattran D.C., Coppo R., Cook H.T., et al. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int 2009; 76 (5): 534-545

33. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40 (9): 1725

34. Weening J.J., D’Agati V.D., Schwartz M.M. et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. JASN 2004; 15 (2): 241-250

35. Schena F.P. Survey of the Italian Registry of Renal Biopsies. Frequency of the renal diseases for 7 consecutive years. Nephrol, Dial, Transplant 1997; 12 (3): 418-426

36. Swaminathan S., Leung N., Lager D.J. et al. Changing incidence of glomerular disease in Olmsted County, Minnesota: a 30-year renal biopsy study. CJASN 2006; 1 (3): 483-487

37. Konishi K., Moller D.R., Saltini C. et al. Spontaneous expression of the interleukin 2 receptor gene and presence of functional interleukin 2 receptors on T lymphocytes in the blood of individuals with active pulmonary sarcoidosis. J Clin Invest 1988; 82 (3): 775-781

38. Bargagli E., Mazzi A., Rottoli P. Markers of inflammation in sarcoidosis: blood, urine, BAL., sputum, and exhaled gas. Clin Chest Med 2008; 29 (3): 445-458

39. Miyara M., Amoura Z., Parizot C. et al. The immune paradox of sarcoidosis and regulatory T cells. J Exp Med 2006; 203 (2): 359-370

40. Zhang S., Audard V., Fan Q. et al. Immunopathogenesis of idiopathic nephrotic syndrome. Contrib Nephrol 2011; 169: 94-106

41. Agostini C., Adami F., Semenzato G. New pathogenetic insights into the sarcoid granuloma. Curr Opin Rheumatol 2000; 12 (1): 71-76

42. Laflam P.F., Garin E.H. Effect of tumor necrosis factor alpha and vascular permeability growth factor on albuminuria in rats. Pediatr Nephrol 2006; 21 (2): 177-181

43. Noel L.H., Zanetti M., Droz D. et al. Long-term prognosis of idiopathic membranous glomerulonephritis. Study of 116 untreated patients. Am J Med 1979; 66 (1): 82-90

44. Schieppati A., Mosconi L., Perna A. et al. Prognosis of untreated patients with idiopathic membranous nephropathy. N Eng J Med 1993; 329 (2): 85-89

45. Ponticelli C., Zucchelli P., Passerini P. et al. A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy. Kidney Int 1995; 48 (5): 1600-1604

46. Jha V., Ganguli A., Saha T.K. et al. A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy. JASN 2007; 18 (6): 1899-1904

47. Barratt J., Smith A.C., Molyneux K., Feehally J. Immunopathogenesis of IgAN. Semin Immunopathol 2007; 29 (4): 427-443

48. Wesemann D.R., Costenbader K.H., Coblyn J.S. Co-existing sarcoidosis, systemic lupus erythematosus and the antiphospholipid antibody syndrome: case reports and discussion from the Brigham and Women’sHospital Lupus Center. Lupus 2009; 18 (3): 202-205

49. Rajoriya N., Wotton C.J., Yeates D.G. et al. Immunemediated and chronic inflammatory disease in people with sarcoidosis: disease associations in a large UK database. Postgrad Med J 2009; 85 (1003): 233-237

50. Weinberg I., Vasiliev L., Gotsman I. Anti-dsDNA antibodies in sarcoidosis. Semin Arthritis Rheum 2000; 29 (5): 328-331

51. Nishiki M., Murakami X., Yamane X., Kato Y. Steroid-sensitive nephrotic syndrome, sarcoidosis and thyroiditis-a new syndrome? Nephrol, Dial, Transplant 1999; 14 (8): 2008-2010